Moderna refuses to hand over to China core intellectual property behind COVID vaccine development: Report Ruchika Sharma3 Oct 2022 10:45 AM GMTThe company had "given up" on its previous efforts to access the Chinese market because of China's demand that it hand over the technology as a...
Moderna seeks USFDA nod for Omicron-targeted COVID vaccine for adolescents, children Ruchika Sharma25 Sep 2022 5:00 AM GMTUS: Moderna Inc said on Friday it has requested U.S. authorization for use of its Omicron-targeting COVID vaccine in adolescents and children.The...
Moderna bivalent COVID booster vaccine gets interim nod in Singapore Ruchika Sharma15 Sep 2022 7:45 AM GMTSingapore: Singapore on Wednesday granted interim authorisation for a bivalent COVID-19 booster vaccine made by Moderna, the government said in a...
Pfizer COVID vaccine approved for kids under 5 in Canada MD Bureau11 Sep 2022 10:16 AM GMTIt's the second vaccine approved for that age group after Health Canada approved Moderna's Spikevax in July.
Moderna Omicron-targeting bivalent COVID-19 booster vaccine gets Canadian approval Ruchika Sharma4 Sep 2022 4:30 AM GMTCambridge: Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, has announced that Health Canada has...
Alleging patent infringement, Moderna sues Pfizer-BioNtech over use of mRNA technology in COVID vaccine Ruchika Sharma27 Aug 2022 11:30 AM GMTPfizer said the company was confident in its intellectual property and would vigorously defend against the allegations.
Moderna seeks USFDA nod for COVID booster tailored against Omicron subvariants Ruchika Sharma24 Aug 2022 7:45 AM GMTThe submission also includes clinical trial data for its BA.1 Omicron-targeting bivalent booster candidate, which was last week cleared in Britain.
Moderna to supply 12 million doses of Omicron containing bivalent COVID booster vaccines to Govt of Canada Ruchika Sharma22 Aug 2022 4:00 AM GMTCambridge: Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the Government...
UK first to approve Omicron COVID vaccine with Moderna approval Ruchika Sharma17 Aug 2022 8:30 AM GMTThe MHRA's Moderna decision was based on clinical trial data that showed the booster triggered "a strong immune response" against both Omicron (BA.1)...
Moderna gets Australian provisional approval for mRNA COVID-19 vaccine Spikevax in children aged 6 months to 5 years Ruchika Sharma20 July 2022 10:12 AM GMTCambridge: Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, has announced that the Therapeutic Goods...
Moderna COVID vaccine SPIKEVAX gets nod in Canada for children aged 6 months to 5 years Ruchika Sharma15 July 2022 10:00 AM GMTCambridge: Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, has announced that Health Canada has...
Moderna to advance two Omicron vaccine candidates against newer variants Ruchika Sharma12 July 2022 10:19 AM GMTCambridge: Moderna Inc said on Monday it was advancing two Omicron vaccine candidates for the fall, one designed against the BA.1 variant and another...
